|
USA-VA-RED HOUSE Κατάλογοι Εταιρεία
|
Εταιρικά Νέα :
- Clinical Trials for Ulcerative Colitis - NIDDK
The trials look to find new ways to prevent, detect, or treat disease and improve quality of life What are clinical trials for ulcerative colitis? Clinical trials—and other types of clinical studies—are part of medical research and involve people like you When you volunteer to take part in a clinical study, you help doctors and
- Ulcerative Colitis in Adults – Guidelines+ Trials Rundown
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis Study Details | Source Sponsor: Pfizer; The purpose of this open-label extension (OLE) study is to evaluate the safety and efficacy of etrasimod in participants with moderately to severely active ulcerative colitis (UC) who previously received double-blind treatment (either etrasimod 2 mg per day or placebo
- Ulcerative Colitis: Clinical Trial Endpoints Guidance for . . .
44 45 UC is a chronic, relapsing disease characterized by diffuse mucosal inflammation of the colon 46 (Langan, Gotsch, et al 2007) The precise etiology of UC is unknown; however, it is thought to
- Clinical Studies, Trial Design Data | UC | Omvoh . . .
The mean duration of ulcerative colitis in years was 7 1 (standard deviation 6 7) in the Omvoh group and 6 9 (standard deviation 7 0) in the placebo group The disease location was left-side colitis in 500 patients (62 9%) in the Omvoh group and 169 patients (63 5%) in the placebo group
- Ulcerative Colitis Clinical Trials - Mayo Clinic Research
Subjects with Ulcerative Colitis who have completed an induction study with PF-00547659 will receive an additional 72 weeks of open-label treatment to evaluate the long-term safety of the drug A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis Rochester, MN
|
|